✦ LIBER ✦

An oncolytic adenovirus expressing herpes simplex virus-thymidine kinase for targeting cancer therapy: Anin vitroevaluation

✍ Scribed by Fei-qun Zheng; Yin Xu; Yi-de Qin; Ren-jie Yang; Jun Han

Book ID: 107466961
Publisher: Chinese Anti-Cancer Association
Year: 2009
Tongue: English
Weight: 617 KB
Volume: 21
Category: Article
ISSN: 1000-9604
DOI: 10.1007/s11670-009-0090-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer-specific targeting of an adenovir

Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control

✍ J. Michael Mathis; B. Jill Williams; Don A. Sibley; Jennifer L. Carroll; Jie Li; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

## Abstract Two technical hurdles, gene delivery and target specificity, have hindered the development of effective cancer gene therapies. In order to circumvent the problem of tumor specificity, the suicide gene, HSV‐1 thymidine kinase (HSV‐Tk), was modified with a complex 5′ upstream‐untranslated

Production and characterization of a bic

Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer

✍ Pizzato, M; Franchin, E; Calvi, P; Boschetto, R; Colombo, M; Ferrini, S; Palù, G 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB

Adenovirus-mediated herpes simplex virus

Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer

✍ Simon J. Hall; Steven E. Mutchnik; Shu-Hsia Chen; Savio L.C. Woo; Timothy C. Tho 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 106 KB 👁 2 views

It is critical to develop new therapies, such as gene therapy, which can impact on both local and metastatic prostate cancer progression. We have developed an orthotopic mouse model of metastatic prostate cancer using a cell line (RM-1) derived from the mouse prostate reconstitution (MPR) model syst